Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Corcept Therapeutics shares surge on positive late-stage ovarian cancer trial results
12:44pm, Monday, 31'st Mar 2025
Corcept Therapeutics (NASDAQ:CORT) shares surged more than 85% after the company announced positive results from its Phase 3 ROSELLA trial, evaluating relacorilant combined with nab-paclitaxel in pat
Corcept's ovarian cancer combination drug meets main goal in late-stage study
08:18am, Monday, 31'st Mar 2025
Corcept Therapeutics said on Monday its experimental ovarian cancer drug in combination with chemotherapy met the main goal of a late-stage trial.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinolog
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?
12:36pm, Friday, 28'th Mar 2025
Corcept (CORT) reported earnings 30 days ago. What's next for the stock?
Did Corcept Therapeutics Incorporated Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CORT
07:30am, Friday, 28'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
Corcept Therapeutics Incorporated (CORT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
07:25am, Thursday, 27'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
CORT ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Corcept Therapeutics Incorporated investment
07:25am, Wednesday, 26'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
CORT STOCK ALERT: Levi & Korsinsky Notifies Corcept Therapeutics Incorporated Investors of an Ongoing Investigation
07:25am, Tuesday, 25'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
Corcept Therapeutics Incorporated Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CORT
07:25am, Monday, 24'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?
10:40am, Friday, 21'st Mar 2025
Here is how Corcept Therapeutics (CORT) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated")
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
12:28pm, Monday, 17'th Mar 2025
NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investor
